Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate and Ventilatory Response to Exercise
NCT03057535Phase 1Completed
- Sponsor
- McGill University
- Start
- May 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sodium bicarbonate in chronic cardiopulmonary disease, sponsored by McGill University. Primary endpoint: Ventilatory equivalent to carbon dioxide nadir at 3 weeks. Started May 2015; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
chronic cardiopulmonary disease
Beyond the preview
Go deeper on NCT03057535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057535.